vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and USCB FINANCIAL HOLDINGS, INC. (USCB). Click either name above to swap in a different company.

PETMED EXPRESS INC is the larger business by last-quarter revenue ($40.7M vs $22.2M, roughly 1.8× USCB FINANCIAL HOLDINGS, INC.). USCB FINANCIAL HOLDINGS, INC. runs the higher net margin — 6.1% vs -26.0%, a 32.1% gap on every dollar of revenue. On growth, USCB FINANCIAL HOLDINGS, INC. posted the faster year-over-year revenue change (14.7% vs -23.3%). USCB FINANCIAL HOLDINGS, INC. produced more free cash flow last quarter ($42.5M vs $-9.2M). Over the past eight quarters, USCB FINANCIAL HOLDINGS, INC.'s revenue compounded faster (12.3% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

USCB Financial Holdings, Inc. is a U.S.-headquartered bank holding company that offers comprehensive retail and commercial banking services, including deposit products, personal and business loans, wealth management, and digital banking tools. It primarily serves individual consumers, small and medium-sized enterprises, and local corporate clients across its operating regions in the United States, prioritizing personalized customer experiences and community-oriented financial services.

PETS vs USCB — Head-to-Head

Bigger by revenue
PETS
PETS
1.8× larger
PETS
$40.7M
$22.2M
USCB
Growing faster (revenue YoY)
USCB
USCB
+38.0% gap
USCB
14.7%
-23.3%
PETS
Higher net margin
USCB
USCB
32.1% more per $
USCB
6.1%
-26.0%
PETS
More free cash flow
USCB
USCB
$51.7M more FCF
USCB
$42.5M
$-9.2M
PETS
Faster 2-yr revenue CAGR
USCB
USCB
Annualised
USCB
12.3%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
USCB
USCB
Revenue
$40.7M
$22.2M
Net Profit
$-10.6M
$1.4M
Gross Margin
23.3%
Operating Margin
-25.7%
14.7%
Net Margin
-26.0%
6.1%
Revenue YoY
-23.3%
14.7%
Net Profit YoY
-1392.6%
-80.3%
EPS (diluted)
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
USCB
USCB
Q4 25
$40.7M
$22.2M
Q3 25
$44.4M
$25.0M
Q2 25
$51.2M
$24.4M
Q1 25
$50.8M
$22.8M
Q4 24
$52.0M
$23.0M
Q3 24
$58.0M
$21.5M
Q2 24
$66.2M
$20.5M
Q1 24
$65.1M
$17.6M
Net Profit
PETS
PETS
USCB
USCB
Q4 25
$-10.6M
$1.4M
Q3 25
$-8.5M
$8.9M
Q2 25
$-34.2M
$8.1M
Q1 25
$-11.6M
$7.7M
Q4 24
$-707.0K
$6.9M
Q3 24
$2.3M
$6.9M
Q2 24
$3.8M
$6.2M
Q1 24
$-5.0M
$4.6M
Gross Margin
PETS
PETS
USCB
USCB
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
PETS
PETS
USCB
USCB
Q4 25
-25.7%
14.7%
Q3 25
-18.9%
47.3%
Q2 25
-66.7%
44.0%
Q1 25
-11.9%
44.2%
Q4 24
-0.9%
39.6%
Q3 24
1.0%
42.5%
Q2 24
6.6%
39.8%
Q1 24
-5.9%
34.3%
Net Margin
PETS
PETS
USCB
USCB
Q4 25
-26.0%
6.1%
Q3 25
-19.2%
35.8%
Q2 25
-66.7%
33.4%
Q1 25
-22.9%
33.5%
Q4 24
-1.4%
30.0%
Q3 24
4.0%
32.3%
Q2 24
5.7%
30.3%
Q1 24
-7.7%
26.2%
EPS (diluted)
PETS
PETS
USCB
USCB
Q4 25
$-0.50
Q3 25
$-0.41
$0.45
Q2 25
$-1.65
Q1 25
$-0.56
Q4 24
$-0.03
Q3 24
$0.11
$0.35
Q2 24
$0.18
Q1 24
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
USCB
USCB
Cash + ST InvestmentsLiquidity on hand
$26.9M
$38.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.8M
$217.2M
Total Assets
$88.0M
$2.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
USCB
USCB
Q4 25
$26.9M
$38.5M
Q3 25
$36.1M
$56.8M
Q2 25
$41.1M
$54.8M
Q1 25
$54.7M
$98.0M
Q4 24
$50.1M
$77.0M
Q3 24
$52.0M
$38.5M
Q2 24
$46.0M
$77.3M
Q1 24
$55.3M
$126.5M
Stockholders' Equity
PETS
PETS
USCB
USCB
Q4 25
$32.8M
$217.2M
Q3 25
$43.1M
$209.1M
Q2 25
$51.5M
$231.6M
Q1 25
$85.1M
$225.1M
Q4 24
$96.2M
$215.4M
Q3 24
$96.4M
$213.9M
Q2 24
$93.5M
$201.0M
Q1 24
$96.7M
$195.0M
Total Assets
PETS
PETS
USCB
USCB
Q4 25
$88.0M
$2.8B
Q3 25
$100.3M
$2.8B
Q2 25
$109.8M
$2.7B
Q1 25
$148.7M
$2.7B
Q4 24
$144.8M
$2.6B
Q3 24
$146.0M
$2.5B
Q2 24
$152.7M
$2.5B
Q1 24
$169.9M
$2.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
USCB
USCB
Operating Cash FlowLast quarter
$-9.2M
$42.8M
Free Cash FlowOCF − Capex
$-9.2M
$42.5M
FCF MarginFCF / Revenue
-22.7%
191.4%
Capex IntensityCapex / Revenue
0.1%
1.4%
Cash ConversionOCF / Net Profit
31.40×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$95.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
USCB
USCB
Q4 25
$-9.2M
$42.8M
Q3 25
$-2.2M
$20.1M
Q2 25
$-12.3M
$18.0M
Q1 25
$7.0M
$14.6M
Q4 24
$-1.2M
$34.8M
Q3 24
$7.4M
$11.3M
Q2 24
$-8.5M
$18.3M
Q1 24
$7.1M
$8.1M
Free Cash Flow
PETS
PETS
USCB
USCB
Q4 25
$-9.2M
$42.5M
Q3 25
$-4.8M
$20.0M
Q2 25
$-13.6M
$18.0M
Q1 25
$4.6M
$14.6M
Q4 24
$-1.9M
$34.5M
Q3 24
$6.1M
$11.2M
Q2 24
$-9.2M
$18.2M
Q1 24
$5.9M
$8.0M
FCF Margin
PETS
PETS
USCB
USCB
Q4 25
-22.7%
191.4%
Q3 25
-10.8%
80.3%
Q2 25
-26.5%
73.7%
Q1 25
9.1%
63.9%
Q4 24
-3.7%
150.2%
Q3 24
10.6%
52.2%
Q2 24
-13.9%
88.8%
Q1 24
9.0%
45.4%
Capex Intensity
PETS
PETS
USCB
USCB
Q4 25
0.1%
1.4%
Q3 25
5.9%
0.5%
Q2 25
2.5%
0.2%
Q1 25
4.7%
0.2%
Q4 24
1.5%
1.4%
Q3 24
2.2%
0.4%
Q2 24
1.0%
0.4%
Q1 24
1.9%
0.5%
Cash Conversion
PETS
PETS
USCB
USCB
Q4 25
31.40×
Q3 25
2.25×
Q2 25
2.22×
Q1 25
1.91×
Q4 24
5.05×
Q3 24
3.18×
1.63×
Q2 24
-2.27×
2.95×
Q1 24
1.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

USCB
USCB

Segment breakdown not available.

Related Comparisons